Janus Henderson Group PLC 4 D Molecular Therapeutics, Inc. Transaction History
Janus Henderson Group PLC
- $182 Billion
- Q2 2024
A detailed history of Janus Henderson Group PLC transactions in 4 D Molecular Therapeutics, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 3,196,762 shares of FDMT stock, worth $25.2 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
3,196,762
Previous 3,197,444
0.02%
Holding current value
$25.2 Million
Previous $102 Million
34.13%
% of portfolio
0.04%
Previous 0.06%
Shares
15 transactions
Others Institutions Holding FDMT
# of Institutions
148Shares Held
57.4MCall Options Held
55.6KPut Options Held
53.7K-
Ra Capital Management, L.P. Boston, MA5.1MShares$40.1 Million1.61% of portfolio
-
Black Rock Inc. New York, NY4.9MShares$38.5 Million0.0% of portfolio
-
Vr Adviser, LLC New York, NY4.4MShares$34.6 Million10.13% of portfolio
-
Goldman Sachs Group Inc New York, NY4.13MShares$32.5 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.06MShares$32 Million2.8% of portfolio
About 4D Molecular Therapeutics, Inc.
- Ticker FDMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 32,382,400
- Market Cap $255M
- Description
- 4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...